Sanofi ADR Earnings, Revenue beat In Q3

  • Investing.com
Sanofi ADR Earnings, Revenue beat In Q3
Credit: © Reuters.

Investing.com - Sanofi (PA: SASY ) ADR reported third quarter earnings that beat analysts' expectations on Thursday and revenue that topped forecasts.

The firm reported earnings per share of €1.26 on revenue of €12.1B. Analysts polled by Investing.com anticipated EPS of €1.15 on revenue of €11.99B. .

For the year, Sanofi ADR shares are up 41%, outperforming the AEX which is up 30.35% year to date.

Sanofi ADR follows other major Healthcare sector earnings this month


On Tuesday, October 19, 2021, J&J reported third quarter EPS of €2.6 on revenue of €23.34B, compared to forecasts of EPS of €2.35 on revenue of €23.64B.

Thermo Fisher Scientific earnings beat analyst's expectations on Wednesday, with third quarter EPS of €5.76 on revenue of €9.33B. Investing.com analysts expected EPS of €4.68 on revenue of €8.33B

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100